🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In order to assess the risk of hepatitis B reactivation in people living wi...
Status
Unknown
Location
CHU NiICE
Start Date
2024-05-20
Trial ID
NCT06421259
The goal of this clinical study is to learn how safe it is to switch to an ...
Status
Completed
Location
Franco Felizarta, MD
Start Date
2023-12-13
Trial ID
NCT06104306
Treatments Being Tested
Dolutegravir (DTG) is a well-tolerated 2nd generation integrase strand tran...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-11-18
Trial ID
NCT04019873
Treatments Being Tested
Clinical approach to HIV infection treatment is based on the use of highly ...
Status
Completed
Location
Clinica delle Malattie Infettive, Policlinico Universitario
Start Date
2014-09-30
Trial ID
NCT01792570
Treatments Being Tested
The RELATIVITY study is a nationwide, multicenter, ambispective observation...
Status
Active Not Recruiting
Location
Hospital Universitario de Burgos
Start Date
2024-12-31
Trial ID
NCT07703748
To evaluate the incidence of grade 3 or 4 transaminase elevations or grade ...
Status
Completed
Location
Fundación Pública Andaluza Progreso y Salud
Start Date
2014-05
Trial ID
NCT02196064
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
Prospective, multicenter study to evaluate tolerability, adherence and effi...
Status
Completed
Location
Angers University Hospital
Start Date
2018-03-15
Trial ID
NCT03451032
Treatments Being Tested
This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2017-10-27
Trial ID
NCT03299049
The purpose of this pharmacokinetic (PK) trial is to evaluate whether the E...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-01
Trial ID
NCT05156658
Treatments Being Tested